Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Equity Group consolidated Interim Report 1 January - 30 June 2026
Consolidated Interim Report 1 January – 30 June 2026 On 14 August 2026, the Board of Directors and the Executive Board of Pharma Equity Group A/S ('PEG', 'The Company' or the 'Group') considered and approved the interim report for the Group…
Swiss Economy Surges Far More Than Forecast, Led by Pharma
Swiss growth momentum surged to the fastest pace since 2021, highlighting the economy's resilience to higher energy costs and lingering trade uncertainty. Gross domestic product adjusted for large sport events rose 1.5% in the second quarter from…
Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call Transcript
Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call August 14, 2026 9:00 AM EDT Panna Sharma - President, CEO & Director David Margrave - CFO & Secretary Good morning and welcome to our Second Quarter 2026 Earnings call. As a reminder, this call is…
U.S. FDA issues warning letter to Aurobindo Pharma's subsidiary Eugia Pharma
A formulation manufacturing facility of Aurobindo Pharma subsidiary near Hyderabad has been issued a warning letter by the U.S. Food and Drug Administration (U.S. FDA). The action on the facility of Eugia Pharma Specialities, the subsidiary…
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?
While Fidelity MSCI Health Care Index ETF (FHLC -0.20%) provides broad healthcare exposure at a very low cost, iShares U.S. Pharmaceuticals ETF (IHE +0.01%) offers a concentrated focus on the domestic pharmaceutical sector for investors seeking…
Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDA
Aurobindo Pharma on Friday said the US health regulator has issued a warning letter to a formulation manufacturing facility of its arm, Eugia Pharma Specialities Ltd, in Telangana. In May this year the company had stated that the US Food and Drug…
Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen
Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was downgraded by research analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a research report issued to clients and investors on Saturday. A number of other brokerages have also…
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded at Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a research note issued to investors on Saturday. Can BioMarin Stock Live Up to Wall Street's High…
Natco Pharma's Q1 net down 57% at ₹206 crore; to raise ₹2,000 crore
Natco Pharma's consolidated net profit declined 57 per cent at ₹206 crore in the first quarter ended June 30, 2026, compared to ₹480 crore for the corresponding quarter last year. The total revenue of the Hyderabad based company stood…
Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Up - What's Next?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price gapped up before the market opened on Friday. The stock had previously closed at $19.23, but opened at $20.30. Nuvectis Pharma shares last traded at $19.1150, with a volume of…
Correction to Consolidated Interim Report 1 January - 30 June 2026
Correction to Consolidated Interim Report 1 January – 30 June 2026 The previous announcement with the half year report was missing the report. The announcement is re-published, including the report. On 14 August 2026, the Board of Directors…
Health Care Down on Growth Doubts - Health Care Roundup
Health-care companies fell amid doubts about the growth outlook for the sector. Pfizer shares were more or less flat after Albert Bourla, chief executive of the Big Pharma company, bought $1 million worth of shares, the latest major insider…
US government report reveals mass insurance fraud in the gender change industry
Please or to access all these features Feminism: Sex and gender discussions Big news. The extent of this is appalling, but not surprising. With WPATH admitting its ideas have no basis the foundations behind the huge gender medical industry in the…
Applying A Marketplace Model To Healthcare Benefits
Bill Oldham is President of AscellaHealth, a global healthcare company enabling access to therapies for rare and complex conditions. Imagine a random Tuesday afternoon in late August. While much of corporate America is still in summer vacation…
Czech Tour: Netcompany Ineos dominate stage 2 to deliver AJ August to mountaintop victory and race lead
AJ August capitalised on a strong Netcompany Ineos team effort to soar to victory and into the race lead on stage 2 of the Czech Tour, finishing atop a 15km climb to Ještěd. Ineos had paced for almost all of the long final climb, with…
Receive a Daily briefing on Pharma Industry News
Get Started